Population Health Investment Co., Inc. Unit
PHICU
PHICU was delisted on the 25th of November, 2022.
15 hedge funds and large institutions have $9.46M invested in Population Health Investment Co., Inc. Unit in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
7% less capital invested
Capital invested by funds: $10.1M → $9.46M (-$685K)
21% less funds holding
Funds holding: 19 → 15 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
ExodusPoint Capital Management
New York
|
-$494K |
| 2 |
CF
Cantor Fitzgerald
New York
|
-$241K |
| 3 |
Morgan Stanley
New York
|
-$19.9K |
| 4 |
Jane Street
New York
|
-$7.08K |
| 5 |
CS
Clear Street
New York
|
-$4K |
PHICU Hedge Fund Activity: Q3 2022 in Review
15 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Population Health Investment Co., Inc. Unit (PHICU) for Q3 2022, worth a combined $9.46M — down 6.8% from $10.1M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PHICU and 0 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was ExodusPoint Capital Management, exiting entirely with an estimated $494K sold.
- 15 institutional investors held Population Health Investment Co., Inc. Unit (PHICU) as of Q3 2022, down from 19 in Q2 2022.
- Funds reported $9.46M of Population Health Investment Co., Inc. Unit stock for Q3 2022, down 6.8% quarter-over-quarter.
- 0 funds opened new Population Health Investment Co., Inc. Unit positions in Q3 2022 and 4 closed out, a net change of -4 holders.
- The largest Population Health Investment Co., Inc. Unit seller in Q3 2022 was ExodusPoint Capital Management, an estimated $494K sold.
Based on aggregated 13F filings for Q3 2022.